The aim of the themed issue is to bring together the most recent research on psychosocial treatments at different stages of development for tobacco users with mental health symptoms. In addition to submissions focusing directly on psychosocial treatments, we welcome submissions of studies with direct psychosocial treatment implications for tobacco users with mental health symptoms (e.g., laboratory studies of factors that could be targeted in psychosocial interventions). Submissions focusing on symptoms related to a range of psychiatric disorders (e.g., mood, anxiety, psychotic, substance use) and tobacco products (including electronic cigarettes) will be encouraged.
Examples of possible manuscript topics include, but are not limited to:
• Randomized clinical trials of psychosocial treatments for tobacco users with mental health symptoms.
• Studies of combined pharmacological and psychosocial treatments that allow conclusions to be drawn about the efficacy of the psychosocial component (e.g., compare an active vs. control psychosocial treatment).
• Factorial designs (SMART, MOST) in which psychosocial treatment components are experimentally manipulated in a population of tobacco users with mental health symptoms.
• Laboratory studies examining outcomes with psychosocial treatment implications for tobacco users with mental health symptoms (e.g., identifying potential targets of psychosocial treatments).
• Contingency management interventions for tobacco users with mental health symptoms. 
